Mayo Clinic at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
Mayo Clinic brings 28 presentations to ObesityWeek 2026 in National Harbor. Its program focuses on predicting who responds to GLP-1 drugs such as semaglutide, using machine learning calculators, gene risk scores and models of weight regain after stopping treatment. It also covers adipose tissue biology, from circadian clock disruption under continuous feeding to inflammation after bariatric surgery.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
Mayo Clinic Rochester, MN | |
Nonprofit academic medical center based in Rochester, Minnesota, with campuses in Arizona and Florida. | Talk Sat Nov 14 1:45pm–2:00pm Session Sat Nov 14 4:30pm–5:30pm Talk Sat Nov 14 4:30pm–4:45pm Talk Sun Nov 15 9:00am–9:15am Session Sun Nov 15 10:30am–11:30am Talk Sun Nov 15 10:30am–11:15am Why One Size Will Never Fit All: Biological Diversity in Obesity and Treatment Response Explores why people respond so differently to anti-obesity drugs and metabolic surgery, and how biological variation could guide more personalized obesity care. Neuroscience of appetite and eatingInterventional and clinical studiesClinical obesity care and professional practiceBariatric surgery and devices Poster Sun Nov 15 2:30pm–3:30pm Aleniglipron in Participants Living with Overweight or Obesity: ACCESS Trial Open-Label Extension Obesity pharmacotherapy and drug developmentInterventional and clinical studies Poster Sun Nov 15 2:30pm–3:30pm Weight History and Eating Behaviors in Adults Undergoing Bariatric Surgery Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Women's Experiences with GLP-1 Receptor Agonists: Qualitative Insights from the WISH Study Clinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Early Treatment Response and Gene Risk Score for Satiation Stratify Weight Loss Trajectories for GLP-1 Receptor Agonists Clinical obesity care and professional practicePopulation health and epidemiology Poster Sun Nov 15 2:30pm–3:30pm Baseline Predictors of Semaglutide and Tirzepatide Induced Nausea and Vomiting: A Real-World Multivariable Analysis Metabolism and integrative physiology Poster Sun Nov 15 2:30pm–3:30pm Weight Maintenance After Side Effects-Prompted GLP-1 Treatment De-escalation in Adults With Obesity Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Adipose Tissue Inflammation After Weight Loss Through Bariatric Surgery and Lifestyle Intervention Interventional and clinical studiesObesity pharmacotherapy and drug development Poster Sun Nov 15 2:30pm–3:30pm A Machine Learning-Derived Gene Risk Score and Semaglutide Response in Adolescents With Obesity Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm Semaglutide Discontinuation in Adolescents With Obesity: Real World Patterns and Subsequent Therapy Obesity pharmacotherapy and drug developmentClinical obesity care and professional practice Poster Sun Nov 15 2:30pm–3:30pm What Patients Want: Are Weight-Loss Goals Realistic Relative to the Strategies Patients Are Willing to Adopt? Interventional and clinical studies Session Sun Nov 15 3:30pm–4:30pm Talk Sun Nov 15 5:10pm–5:20pm A Machine Learning-Derived Gene Risk Score and Semaglutide Response in Adolescents With Obesity Metabolism and integrative physiologyObesity pharmacotherapy and drug developmentPediatric and adolescent obesityBariatric surgery and devicesNutrition, diet and foodInterventional and clinical studies Talk Mon Nov 16 10:15am–10:30am Talk Mon Nov 16 10:25am–10:30am Graded Cardiometabolic Benefits Across Weight-Loss Response With GLP-1-Based Therapies Metabolism and integrative physiologyNeuroscience of appetite and eatingInterventional and clinical studiesPopulation health and epidemiologyPolicy and public health Poster Mon Nov 16 2:30pm–3:30pm Diet Quality and Fat Deposition: Ultra-Processed Food Intake Beyond Energy Intake Population health and epidemiology Poster Mon Nov 16 2:30pm–3:30pm Graded Cardiometabolic Benefits Across Weight-Loss Response With GLP-1–Based Therapies Chronic disease and obesity complications Talk Mon Nov 16 4:00pm–4:15pm Talk Mon Nov 16 5:30pm–5:50pm Stigma-related Trauma and Obesity Care Complexity Clinical obesity care and professional practiceBariatric surgery and devicesNutrition, diet and food Talk Mon Nov 16 5:50pm–6:10pm Integrating Trauma Screening Into Obesity Treatment Pathways Clinical obesity care and professional practiceBariatric surgery and devicesNutrition, diet and food Talk Mon Nov 16 6:00pm–6:15pm Talk Tue Nov 17 8:40am–9:00am When Food Stops Working: Clinical Care After MBS and Incretin Therapy Clinical obesity care and professional practice Talk Tue Nov 17 8:45am–9:00am |
Find decision makers at Mayo Clinic
Tell us what you sell and we’ll find the people at Mayo Clinic most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction